Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CD19' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 148 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Cherukuri, A; Cheng, PC; Sohn, HW; Pierce, SK
      The CD19/CD21 complex functions to prolong B cell antigen receptor signaling from lipid rafts

      IMMUNITY
    2. Mavrangelos, C; Thiel, M; Adamson, PJ; Millard, DJ; Nobbs, S; Zola, H; Nicholson, IC
      Increased yield and activity of soluble single-chain antibody fragments bycombining high-level expression and the Skp periplasmic chaperonin

      PROTEIN EXPRESSION AND PURIFICATION
    3. Cheng, PC; Cherukuri, A; Dykstra, M; Malapati, S; Sproul, T; Chen, MR; Pierce, SK
      Floating the raft hypothesis: the roles of lipid rafts in B cell antigen receptor function

      SEMINARS IN IMMUNOLOGY
    4. Kirchmeier, MJ; Ishida, T; Chevrette, J; Allen, TM
      Correlations between the rate of intracellular release of endocytosed liposomal doxorubicin and cytotoxicity as determined by a new assay

      JOURNAL OF LIPOSOME RESEARCH
    5. Barrington, R; Zhang, M; Fischer, M; Carroll, MC
      The role of complement in inflammation and adaptive immunity

      IMMUNOLOGICAL REVIEWS
    6. Ohnishi, H; Hayashi, Y; Okamura, T; Tabuchi, K; Kobayashi, M; Bessho, F
      An infant with t(4;11)(q21;q23) acute lymphoblastic leukemia successfully treated using immunomagnetically purged autologous bone marrow transplantation

      MEDICAL AND PEDIATRIC ONCOLOGY
    7. Walling, DM; Flaitz, CM; Nichols, CM; Hudnall, SD; Adler-Storthz, K
      Persistent productive Epstein-Barr virus replication in normal epithelial cells in vivo

      JOURNAL OF INFECTIOUS DISEASES
    8. Hasegawa, M; Fujimoto, M; Poe, JC; Steeber, DA; Lowell, CA; Tedder, TF
      A CD19-dependent signaling pathway regulates autoimmunity in Lyn-deficientmice

      JOURNAL OF IMMUNOLOGY
    9. Cherukuri, A; Cheng, PC; Pierce, SK
      The role of the CD19/CD21 complex in B cell processing and presentation ofcomplement-tagged antigens

      JOURNAL OF IMMUNOLOGY
    10. Schmidt, E; Leinfelder, U; Gessner, P; Zillikens, D; Brocker, EB; Zimmermann, U
      CD19(+) B lymphocytes are the major source of human antibody-secreting hybridomas generated by electrofusion

      JOURNAL OF IMMUNOLOGICAL METHODS
    11. Otero, DC; Omori, SA; Rickert, RC
      CD19-dependent activation of Akt kinase in B-lymphocytes

      JOURNAL OF BIOLOGICAL CHEMISTRY
    12. de Fougerolles, AR; Batista, F; Johnsson, E; Fearon, DT
      IgM and stromal cell-associated heparan sulfate/heparin as complement-independent ligands for CD19

      EUROPEAN JOURNAL OF IMMUNOLOGY
    13. Rasmussen, T; Johnsen, HE
      Controversies surrounding the circulating clonotypic B lymphocytes in multiple myeloma - Response

      BLOOD
    14. Iden, DL; Allen, TM
      In vitro and in vivo comparison of immunoliposomes made by conventional coupling techniques with those made by a new post-insertion approach

      BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
    15. Madihally, SV; Toner, M; Yarmush, ML; Mitchell, RN
      Peripheral blood mononuclear cells exhibit hyercatabolic activity in response to thermal injury correlation with diminished MHC I expression

      JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE
    16. Okada, T; Maeda, A; Iwamatsu, A; Gotoh, K; Kurosaki, T
      BCAP: The tyrosine kinase substrate that connects B cell receptor to phosphoinositide 3-kinase activation

      IMMUNITY
    17. Ikemoto, T; Nakagawa, T; Hatanaka, M; Hasegawa, M; Kageyama, T; Hirano, M; Shimizu, A
      My4(+)/LeuM3(-) molecule and CD19 antigen are down-modulate by low affinity Fc gamma receptor II (CD32) stimulation on CD56-positive B-lymphoma cells

      LEUKEMIA & LYMPHOMA
    18. Nakase, K; Bradstock, K; Sartor, M; Gottlieb, D; Byth, K; Kita, K; Shiku, H; Kamada, N
      Geographic heterogeneity of cellular characteristics of acute myeloid leukemia: a comparative study of Australian and Japanese adult cases

      LEUKEMIA
    19. Pyatt, DW; Yang, Y; Stillman, WS; Cano, LL; Irons, RD
      Hydroquinone inhibits PMA-induced activation of NF kappa B in primary human CD19(+) B lymphocytes

      CELL BIOLOGY AND TOXICOLOGY
    20. Sahara, N; Ihara, M; Ono, T; Tamashima, S; Matsui, H; Takeshita, A; Ohno, R
      Multiple myeloma expressing CD19(+)CD56(-) phenotype

      AMERICAN JOURNAL OF HEMATOLOGY
    21. Voss, RH; Lotz, C; Cellary, A; Theobald, M
      Targeting p53, hdm2, and CD19: vaccination and immunologic strategies

      BONE MARROW TRANSPLANTATION
    22. Doody, GM; Billadeau, DD; Clayton, E; Hutchings, A; Berland, R; McAdam, S; Leibson, PJ; Turner, M
      Vav-2 controls NFAT-dependent transcription in B- but not T-lymphocytes

      EMBO JOURNAL
    23. Fujimoto, M; Poe, JC; Hasegawa, M; Tedder, TF
      CD19 regulates intrinsic B lymphocyte signal transduction and activation through a novel mechanism of processive amplification

      IMMUNOLOGIC RESEARCH
    24. Shearer, WT; Easley, KA; Goldfarb, J; Rosenblatt, HM; Jenson, HB; Kovacs, A; McIntosh, K
      Prospective 5-year study of peripheral blood CD4(+), CD8(+), and CD19(+)/CD20(+) lymphocytes and serum Igs in children born to HIV-1(+) women

      JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
    25. Marchbank, KJ; Watson, CC; Ritsema, DF; Holers, VM
      Expression of human complement receptor 2 (CR2, CD21) in Cr2(-/-) mice restores humoral immune function

      JOURNAL OF IMMUNOLOGY
    26. Pogue, SL; Kurosaki, T; Bolen, J; Herbst, R
      B cell antigen receptor-induced activation of Akt promotes B cell survivaland is dependent on Syk kinase

      JOURNAL OF IMMUNOLOGY
    27. Cliff, JM; Klaus, GGB
      A method for investigating the role of homotypic adhesion in lymphocyte activation

      JOURNAL OF IMMUNOLOGICAL METHODS
    28. Wang, XW; Stollar, BD
      Human immunoglobulin variable region gene analysis by single cell RT-PCR

      JOURNAL OF IMMUNOLOGICAL METHODS
    29. Morrison, SG; Morrison, RP
      In situ analysis of the evolution of the primary immune response in murineChlamydia trachomatis genital tract infection

      INFECTION AND IMMUNITY
    30. Gardby, E; Lycke, NY
      CD19-deficient mice exhibit poor responsiveness to oral immunization despite evidence of unaltered total IgA levels, germinal centers and IgA-isotypeswitching in Peyer's patches

      EUROPEAN JOURNAL OF IMMUNOLOGY
    31. Li, XL; Carter, RH
      CD19 signal transduction in normal human a cells: linkage to downstream pathways requires phosphatidylinositol 3-kinase, protein kinase C and Ca2+

      EUROPEAN JOURNAL OF IMMUNOLOGY
    32. Hamalainen, MM; Eskola, JU; Hellman, J; Pulkki, K; Rajamaki, A
      RT-PCR from eosinophil-depleted leukocytes without RNA extraction Cell selection using streptavidin PCR tubes

      CLINICAL BIOCHEMISTRY
    33. de Menezes, DEL; Pilarski, LM; Belch, AR; Allen, TM
      Selective targeting of immunoliposomal doxorubicin against human multiple myeloma in vitro and ex vivo

      BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
    34. Zhu, DM; Fang, WH; Narla, RK; Uckun, FM
      A requirement for protein kinase C inhibition for calcium-triggered apoptosis in acute lymphoblastic leukemia cells

      CLINICAL CANCER RESEARCH
    35. Uckun, FM; Messinger, Y; Chen, CL; O'Neill, K; Myers, DE; Goldman, F; Hurvitz, C; Casper, JT; Levine, A
      Treatment of therapy-refractory B-lineage acute lymphoblastic leukemia with an apoptosis-inducing CD19-directed tyrosine kinase inhibitor

      CLINICAL CANCER RESEARCH
    36. Ghetie, MA; Ghetie, V; Vitetta, ES
      Anti-CD19 antibodies inhibit the function of the P-gp pump in multidrug-resistant B lymphoma cell

      CLINICAL CANCER RESEARCH
    37. Schuster-Kolbe, J; Ludwig, H; Adolf, GR; Heider, KH
      Expression of CD44 isoforms on isolated bone marrow plasma cells and peripheral CD19(+) B cells of patients with multiple myeloma and healthy individuals

      LEUKEMIA & LYMPHOMA
    38. Sato, S
      CD19 is a central response regulator of B lymphocyte signaling thresholds governing autoimmunity

      JOURNAL OF DERMATOLOGICAL SCIENCE
    39. de Menezes, DEL; Kirchmeier, MJ; Gagne, JF; Pilarski, LM; Allen, TM
      Cellular trafficking and cytotoxicity of anti-CD19-targeted liposomal doxorubicin in B lymphoma cells

      JOURNAL OF LIPOSOME RESEARCH
    40. Dunphy, CH
      Comprehensive review of adult acute myelogenous leukemia: Cytomorphological, enzyme cytochemical, flow cytometric immunophenotypic, and cytogenetic findings

      JOURNAL OF CLINICAL LABORATORY ANALYSIS
    41. Brayman, AA; Coppage, ML; Vaidya, S; Miller, MW
      Transient poration and cell surface receptor removal from human lymphocytes in vitro by 1 MHZ ultrasound

      ULTRASOUND IN MEDICINE AND BIOLOGY
    42. Kurosaka, D; LeBien, TW; Pribyl, JAR
      Comparative studies of different stromal cell microenvironments in supportof human B-cell development

      EXPERIMENTAL HEMATOLOGY
    43. Wagle, NM; Kim, JH; Pierce, SK
      CD19 regulates B cell antigen receptor-mediated MHC class II antigen processing

      VACCINE
    44. Bueno, EC; Vaz, AJ; Oliveira, CA; Machado, LR; Livramento, JA; Mielli, SR; Ueda, M
      Analysis of cells in cerebrospinal fluid from patients with neurocysticercosis by means of flow cytometry

      CYTOMETRY
    45. Calado, RT; Garcia, AB; Falcao, RP
      Age-related changes of immunophenotypically immature lymphocytes in normalhuman peripheral blood

      CYTOMETRY
    46. Han, KJ; Kim, Y; Lee, J; Lim, J; Lee, KY; Kang, CS; Kim, WI; Kim, BK; Shim, SI; Kim, SM
      Human basophils express CD22 without expression of CD19

      CYTOMETRY
    47. Venkataraman, C; Shankar, G; Sen, G; Bondada, S
      Bacterial lipopolysaccharide induced B cell activation is mediated via a phosphatidylinositol 3-kinase dependent signaling pathway

      IMMUNOLOGY LETTERS
    48. Gisler, R; Akerblad, P; Sigvardsson, M
      A human early B-cell factor-like protein participates in the regulation ofthe human CD19 promoter

      MOLECULAR IMMUNOLOGY
    49. Rego, EM; Tone, LG; Garcia, AB; Falcao, RP
      CD10 and CD19 fluorescence intensity of B-cell precursors in normal and leukemic bone marrow. Clinical characterization of CD10(+strong) and CD10(+weak) common acute lymphoblastic leukemia

      LEUKEMIA RESEARCH
    50. Chen, CL; Levine, A; Rao, A; O'Neill, K; Messinger, Y; Myers, DE; Goldman, F; Hurvitz, C; Casper, JT; Uckun, FM
      Clinical pharmacokinetics of the CD19 receptor-directed tyrosine kinase inhibitor B43-Genistein in patients with B-lineage lymphoid malignancies

      JOURNAL OF CLINICAL PHARMACOLOGY
    51. Zhuk, EA; Galenok, VA
      The importance of estimated value of T-cell activation in insulin-dependent-diabetes mellitus

      TERAPEVTICHESKII ARKHIV
    52. Kipriyanov, SM; Moldenhauer, G; Schuhmacher, J; Cochlovius, B; Von der Lieth, CW; Matys, ER; Little, M
      Bispecific tandem diabody for tumor therapy with improved antigen binding and pharmacokinetics

      JOURNAL OF MOLECULAR BIOLOGY
    53. Bachmann, MF; Nitschke, L; Krawczyk, C; Tedford, K; Ohashi, PS; Fischer, KD; Penninger, JM
      The guanine-nucleotide exchange factor Vav is a crucial regulator of B cell receptor activation and B cell responses to nonrepetitive antigens

      JOURNAL OF IMMUNOLOGY
    54. Vassilev, A; Ozer, Z; Navara, C; Mahajan, S; Uckun, FM
      Bruton's tyrosine kinase as an inhibitor of the Fas/CD95 death-inducing signaling complex

      JOURNAL OF BIOLOGICAL CHEMISTRY
    55. Le Gall, F; Kipriyanov, SM; Moldenhauer, G; Little, M
      Di-, tri- and tetrameric single chain Fv antibody fragments against human CD19: effect of valency on cell binding

      FEBS LETTERS
    56. Gulbranson-Judge, A; Tybulewicz, VLJ; Walters, AE; Toellner, KM; MacLennan, ICM; Turner, M
      Defective immunoglobulin class switching in Vav-deficient mice is attributable to compromised T cell help

      EUROPEAN JOURNAL OF IMMUNOLOGY
    57. TRIMOREAU F; GACHARD N; JACCARD A; TONI FB; BORDESSOULE D; PRALORAN V
      B-CELL COMPARTMENTS IN MULTIPLE-MYELOMA - FLOW CYTOMETRIC ANALYSIS OFTHEIR LABELING INDEXES AND BCL-2 PROTEIN EXPRESSION

      HEMATOLOGY AND CELL THERAPY
    58. FEARON DT
      THE COMPLEMENT-SYSTEM AND ADAPTIVE IMMUNITY

      Seminars in immunology
    59. FUJIMOTO M; POE JC; INAOKI M; TEDDER TF
      CD19 REGULATES B-LYMPHOCYTE RESPONSES TO TRANSMEMBRANE SIGNALS

      Seminars in immunology
    60. EK O; GAYNON P; ZEREN T; CHELSTROM LM; MYERS DE; UCKUN FM
      TREATMENT OF HUMAN B-CELL PRECURSOR LEUKEMIA IN SCID MICE BY USING A COMBINATION OF THE ANTI-CD19 IMMUNOTOXIN B43-PAP WITH THE STANDARD CHEMOTHERAPEUTIC DRUGS VINCRISTINE, METHYLPREDNISOLONE, AND L-ASPARAGINASE

      Leukemia & lymphoma
    61. EK O; YANISHEVSKI Y; ZEREN T; WAURZYNIAK B; GUNTHER R; CHELSTROM L; CHANDANLANGLIE M; SCHNEIDER E; MYERS DE; EVANS W; UCKUN FM
      IN-VIVO TOXICITY AND PHARMACOKINETIC FEATURES OF B43(ANTI-CD19)-GENISTEIN IMMUNOCONJUGATE

      Leukemia & lymphoma
    62. MYERS DE; SICHENEDER A; CLEMENTSON D; DVORAK N; VENKATACHALAM T; SEV AR; CHANDANLANGLIE M; UCKUN FM
      LARGE-SCALE MANUFACTURING OF B43(ANTI-CD19)-GENISTEIN FOR CLINICAL-TRIALS IN LEUKEMIA AND LYMPHOMA

      Leukemia & lymphoma
    63. EK O; REAMAN GH; CRANKSHAW DL; CHELSTROM LM; MYERS DE; UCKUN FM
      COMBINED THERAPEUTIC EFFICACY OF THE THYMIDYLATE SYNTHASE INHIBITOR ZD1694 (TOMUDEX) AND THE IMMUNOTOXIN B43(ANTI-CD19)-PAP IN A SCID MOUSEMODEL OF HUMAN B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA

      Leukemia & lymphoma
    64. ZHANG M; RAVECHE ES
      APOPTOSIS INDUCTION IN FLUDARABINE RESISTANT MALIGNANT B-1 CELLS BY G2-M CELL-CYCLE ARREST

      Oncology Reports
    65. GINALDI L; DEMARTINIS M; DOSTILIO A; MARINI L; QUAGLINO D
      CHANGES IN ANTIGEN EXPRESSION ON B-LYMPHOCYTES DURING HIV-INFECTION

      Pathobiology
    66. KONCZ G; GERGELY J; SARMAY G
      FC-GAMMA-RIIB INHIBITS BOTH B-CELL-RECEPTOR-INDUCED AND CD19-INDUCED CA2-GAMMA-R-TRANSFECTED HUMAN B-CELLS( MOBILIZATION IN FC)

      International immunology
    67. LEBEIN TW
      B-CELL LYMPHOPOIESIS IN MOUSE AND MAN

      Current opinion in immunology
    68. CARROLL MC; PRODEUS AP
      LINKAGES OF INNATE AND ADAPTIVE IMMUNITY

      Current opinion in immunology
    69. MANABE A; MORI T; EBIHARA Y; KOYAMA T; OKUYAMA I; HOSOYA R; KANEKO M; ISHIMOTO K; NAKAHATA T; NAKAZAWA S
      CHARACTERIZATION OF LEUKEMIC-CELLS IN CD2 CD19 DOUBLE-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA/

      International journal of hematology
    70. MURALI R; WOLFE JH; ERBER R; CHICE SM; MURALI MR; DURKIN HG; ZACH P; AUCI DL
      ALTERED LEVELS OF UROKINASE ON MONOCYTES AND IN SERUM OF CHILDREN WITH AIDS - EFFECTS ON LYMPHOCYTE-ACTIVATION AND SURFACE MARKER EXPRESSION

      Journal of leukocyte biology
    71. FAUST J; HUNT P; SCULLY S; SHALHOUB V
      MULTIPLE-MYELOMA CELLS AND CELLS OF THE HUMAN OSTEOCLAST LINEAGE SHARE MORPHOLOGICAL AND CELL-SURFACE MARKERS

      Journal of cellular biochemistry
    72. LI QZ; HUDSON W; WANG D; BERVEN E; UCKUN FM; KERSEY JH
      PHARMACOKINETICS AND BIODISTRIBUTION OF RADIOIMMUNOCONJUGATES OF ANTI-CD19 ANTIBODY AND SINGLE-CHAIN FV FOR TREATMENT OF HUMAN B-CELL MALIGNANCY

      Cancer immunology and immunotherapy
    73. OGORMAN MRG; MILLARD DD; LOWDER JN; YOGEV R
      LYMPHOCYTE SUBPOPULATIONS IN HEALTHY 1-3-DAY-OLD INFANTS

      Cytometry
    74. SACANELLA E; ESTRUCH R; GAYA A; FERNANDEZSOLA J; ANTUNEZ E; URBANOMARQUEZ A
      ACTIVATED LYMPHOCYTES (CD25(-NOURISHED CHRONIC-ALCOHOLICS WITHOUT ETHANOL-RELATED DISEASES() CD69(+) CELLS) AND DECREASED CD19(+) CELLS IN WELL)

      Alcoholism, clinical and experimental research
    75. FISCHER MB; GOERG S; SHEN LM; PRODEUS AP; GOODNOW CC; KELSOE G; CARROLL MC
      DEPENDENCE OF GERMINAL CENTER B-CELLS ON EXPRESSION OF CD21 CD35 FOR SURVIVAL/

      Science
    76. CAP J; BABUSIKOVA O; KAISEROVA E; JAMARIK M
      EXPRESSION OF CD10, CD19 AND CD34 MARKERS IN BONE-MARROW SAMPLES OF CHILDREN WITH PRECURSOR B-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA IN CLINICALAND HEMATOLOGICAL REMISSION

      Neoplasma
    77. FEHR T; RICKERT RC; ODERMATT B; ROES J; RAJEWSKY K; HENGARTNER H; ZINKERNAGEL RM
      ANTIVIRAL PROTECTION AND GERMINAL CENTER FORMATION, BUT IMPAIRED B-CELL MEMORY IN THE ABSENCE OF CD19

      The Journal of experimental medicine
    78. GINALDI L; DEMARTINIS M; MATUTES E; FARAHAT N; MORILLA R; CATOVSKY D
      LEVELS OF EXPRESSION OF CD19 AND CD20 IN CHRONIC B-CELL LEUKEMIAS

      Journal of Clinical Pathology
    79. VENKATARAMAN C; LU PJ; BUHL AM; CHEN CS; CAMBIER JC; BONDADA S
      CD72-MEDIATED B-CELL ACTIVATION INVOLVES RECRUITMENT OF CD19 AND ACTIVATION OF PHOSPHATIDYLINOSITOL 3-KINASE

      European Journal of Immunology
    80. Nichols, TC; Guthridge, JM; Karp, DR; Molina, H; Fletcher, DR; Holers, VM
      gamma-glutamyl transpeptidase, an ecto-enzyme regulator of intracellular redox potential, is a component of TM4 signal transduction complexes

      EUROPEAN JOURNAL OF IMMUNOLOGY
    81. EBERL G; JIANG S; YU Z; SCHNEIDER P; CORRADIN G; MACH JP
      AN ANTI-CD19 ANTIBODY COUPLED TO A TETANUS TOXIN PEPTIDE INDUCES EFFICIENT FAS LIGAND (FASL)-MEDIATED CYTOTOXICITY OF A TRANSFORMED HUMAN B-CELL LINE BY SPECIFIC CD4(-CELLS() T)

      Clinical and experimental immunology
    82. BOURNE T; ZUKOWSKACOOPER M; SALAMAN MR; SEIFERT MH; ISENBERG DA
      SPONTANEOUS IMMUNOGLOBULIN-PRODUCING CAPACITY OF CULTURES FROM LUPUS PATIENTS AND NORMAL DONORS FOLLOWING DEPLETION OF CELLS EXPRESSING CD19 OR CD38

      Clinical and experimental immunology
    83. KANEKO H; ARIYASU T; INOUE R; FUKAO T; KASAHARA K; TERAMOTO T; MATSUI E; HAYAKAWA S; KONDO N
      EXPRESSION OF PAX5 GENE IN HUMAN HEMATOPOIETIC-CELLS AND TISSUES - COMPARISON WITH IMMUNODEFICIENT DONORS

      Clinical and experimental immunology
    84. GANTNER F; GOTZ C; GEKELER V; SCHUDT C; WENDEL A; HATZELMANN A
      PHOSPHODIESTERASE PROFILE OF HUMAN B-LYMPHOCYTES FROM NORMAL AND ATOPIC DONORS AND THE EFFECTS OF PDE INHIBITION ON B-CELL PROLIFERATION

      British Journal of Pharmacology
    85. THUNBERG U; GIDLOF C; BANGHAGEN M; SALLSTROM JF; SUNDSTROM C; TOTTERMAN T
      HPAII POLYMERASE-CHAIN-REACTION RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISM IN THE HUMAN CD19 GENE ON 16P11

      Human heredity
    86. UCKUN FM; YANISHEVSKI Y; TUMER N; WAURZYNIAK B; MESSINGER Y; CHELSTROM LM; LISOWSKI EA; EK O; ZEREN T; WENDORF H; LANGLIE MC; IRVIN JD; MYERS DE; FULLER GB; EVANS W; GUNTHER R
      PHARMACOKINETIC FEATURES, IMMUNOGENICITY, AND TOXICITY OF B43(ANTI-CD19)-POKEWEED ANTIVIRAL PROTEIN IMMUNOTOXIN IN CYNOMOLGUS MONKEYS

      Clinical cancer research
    87. UCKUN FM; SATHER H; GAYNON P; ARTHUR D; NACHMAN J; SENSEL M; STEINHERZ P; HUTCHINSON R; TRIGG M; REAMAN G
      PROGNOSTIC-SIGNIFICANCE OF THE CD10(-PROGENITOR IMMUNOPHENOTYPE IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA - A REPORT FROM THE CHILDRENSCANCER GROUP()CD19(+)CD34(+) B)

      Leukemia & lymphoma
    88. MIZUTANI M; YAMAGUCHI M; MIWA H; KAWAMURA T; OKUNO T; NISHII K; SHIKU H; KAMADA N; KITA K
      FREQUENT EXPRESSION OF MDR1 AND MDR3 GENES IN ACUTE MYELOCYTIC-LEUKEMIA CELLS WITH T(8-21)(Q22-Q22)

      International journal of oncology
    89. TONNELLE C; DERCOLE C; DEPRAETERE V; METRAS D; BOUBLI L; FOUGEREAU M
      HUMAN THYMIC B-CELLS LARGELY OVEREXPRESS THE V(H)4 IG GENE FAMILY - APOSSIBLE ROLE IN THE CONTROL OF TOLERANCE IN-SITU

      International immunology
    90. OROURKE L; TOOZE R; FEARON DT
      CO-RECEPTORS OF B-LYMPHOCYTES

      Current opinion in immunology
    91. BILLSTROM R; JOHANSSON B; STROMBECK B; ELRIFAI W; LARRAMENDY M; OLOFSSON T; MITELMAN F; KNUUTILA S
      CLONAL CD5-POSITIVE B-LYMPHOCYTES IN MYELODYSPLASTIC SYNDROME WITH SYSTEMIC VASCULITIS AND TRISOMY-8

      Annals of hematology
    92. MIZUTANI M; MIWA H; TAKAHASHI T; KATOH K; SHIKAMI M; KATAYAMA N; SHIKU H; KITA K
      CELLULAR CHARACTERISTICS OF ACUTE-LEUKEMIA CELLS SIMULTANEOUSLY EXPRESSING CD13 CD33, CD7 AND CD19/

      International journal of hematology
    93. MANZKE O; TITZER S; TESCH H; DIEHL V; BOHLEN H
      CD3-X-CD19 BISPECIFIC ANTIBODIES AND CD28 COSTIMULATION FOR LOCOREGIONAL TREATMENT OF LOW-MALIGNANCY NON-HODGKINS-LYMPHOMA

      Cancer immunology and immunotherapy
    94. CAMBIER JC
      POSITIVE AND NEGATIVE SIGNAL COOPERATIVITY IN THE IMMUNE-SYSTEM - THEBCR, FC-GAMMA-RIIB, CR-2 PARADIGM

      Biochemical Society transactions
    95. BROHEE D; NEVE P
      SUBSET-RELATED CHANGES IN HUMAN LYMPHOCYTE CELL-SIZE WITH AGING

      Medical science research
    96. MIYAZAKI T; MULLER U; CAMPBELL KS
      NORMAL DEVELOPMENT BUT DIFFERENTIALLY ALTERED PROLIFERATIVE RESPONSESOF LYMPHOCYTES IN MICE LACKING CD81

      EMBO journal
    97. NICHOLSON IC; LENTON KA; LITTLE DJ; DECORSO T; LEE FT; SCOTT AM; ZOLA H; HOHMANN AW
      CONSTRUCTION AND CHARACTERIZATION OF A FUNCTIONAL CD19 SPECIFIC SINGLE-CHAIN FV FRAGMENT FOR IMMUNOTHERAPY OF B-LINEAGE LEUKEMIA AND LYMPHOMA

      Molecular immunology
    98. MUTHUKKUMAR S; VENKATARAMAN C; WOODS T; BONDADA S
      ACTIVATION OF SYK IN AN IMMATURE B-CELL LINE DOES NOT REQUIRE LYN ACTIVITY

      Molecular immunology
    99. PINTO A; TALLINI G; NOVAK RW; BOWEN T; PARHAM DM
      UNDIFFERENTIATED RHABDOMYOSARCOMA WITH LYMPHOID PHENOTYPE EXPRESSION

      Medical and pediatric oncology
    100. CARTER RH; DOODY GM; BOLEN JB; FEARON DT
      MEMBRANE IGM-INDUCED TYROSINE PHOSPHORYLATION OF CD19 REQUIRES A CD19DOMAIN THAT MEDIATES ASSOCIATION WITH COMPONENTS OF THE B-CELL ANTIGEN RECEPTOR COMPLEX

      The Journal of immunology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 15/01/21 alle ore 19:47:29